Leukemia: Difference between revisions
From IDWiki
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
(restructured) |
||
Line 1: | Line 1: | ||
== |
== Clinical Manifestations == |
||
*Often cytopenia-related symptoms |
|||
* Primary: suspect when multiple lineages affected, significant leukocytosis, lymphadenopathy, splenomegaly |
|||
* Secondary |
|||
** Acute infection (30-50s) |
|||
** Chronic inflammation |
|||
** Stress (MI, surgery, burn) (30-50) |
|||
** Steroids |
|||
** Pregnancy |
|||
** Cigarette smoking |
|||
==Differential Diagnosis== |
|||
== Clinical Manifestations == |
|||
*Primary: suspect when multiple lineages affected, significant [[leukocytosis]], [[lymphadenopathy]], [[splenomegaly]] |
|||
*Secondary |
|||
**Acute infection (30-50%) |
|||
**Chronic inflammation |
|||
**Stress (MI, surgery, burn) (30-50%) |
|||
**Steroids |
|||
**Pregnancy |
|||
**Cigarette smoking |
|||
==Investigations== |
|||
*Urgent blood film review to r/o [[APL]] |
|||
==Management== |
|||
===Acute=== |
|||
*Rule out [[DIC]] (especially seen in [[APL]]) |
|||
==== [[Tumour lysis syndrome]] ==== |
|||
*2 or more: [[hyperkalemia]], [[hyperphosphatemia]], [[hypocalcemia]], [[hyperuricemia]] |
|||
*Causes [[acute kidney injury]], [[Seizure|seizures]], [[Arrhythmia|arrhythmias]] |
|||
*Hydration with normal saline (don't supplement electrolytes), target urine output of 80-100 mL/m<sup>2</sup>/h |
|||
*[[Rasburicase]] to get rid of uric acid (may need to call Nephrology) |
|||
*Treat [[hyperkalemia]] |
|||
*Do NOT treat [[hypocalcemia]] |
|||
==== [[Leukostasis]] ==== |
|||
*More common in [[AML]] than any other |
|||
*Lungs and brain most commonly affected |
|||
*Cytoreduction |
|||
**Induction chemotherapy as soon as possilble |
|||
**Overnight, give [[hydroxyurea]] 2g q6h |
|||
***Can develop tumour lysis syndrome |
|||
**No evidence for [[leukopheresis]] |
|||
==== Suspected [[APL]] ==== |
|||
*Consult Hematology overnight |
|||
* History |
|||
*Start [[ATRA]] 45mg/m<sup>2</sup> divided BID |
|||
** Often cytopenia-related symptoms |
|||
*Beware differentiation syndrome, with fever, effusion, dyspnea, hypotension; treated with steroids |
|||
* Signs & Symptoms |
|||
*Beware [[DIC]] |
|||
**Follow q6h bloodwork |
|||
**Transfuse platelets ≥ 30 |
|||
**[[Cryoprecipitate]] to keep [[fibrinogen]] ≥ 1.5 (regardless of bleeding) |
|||
**[[Plasma]] to keep INR < 1.5 |
|||
**AVOID [[tranexamic acid]] |
|||
===Chronic=== |
|||
== Investigations == |
|||
==== AML ==== |
|||
* Labs |
|||
** Urgent blood film review to r/o APL |
|||
* Imaging |
|||
* Other |
|||
*Induction with 3+7: 3 days of daunorubicin and 7 days of cytarabine, includes about a month as inpatient |
|||
== Management == |
|||
*BM to confirm induction, then consolidation |
|||
**Low risk: 2-3 more cycles of same |
|||
**High/poor risk: 1-2 more cycles, then alloSCT |
|||
=== |
==== APL ==== |
||
*ATRA + arsenic trioxide |
|||
* DIC (especially seen in APL) |
|||
* Tumour lysis syndrome |
|||
** 2 or more: hyperkalemia, hyperphsphatemia, hypocalcemia, hyperuricemia |
|||
** causes renal dysfunction, seizures, arrhythmias |
|||
** Hydration with IVNS (don't supplement electrolytes), target urine output of 80-100 mL/m2/h |
|||
** Rasburicase to get rid of uric acid (may need to call nephrology) |
|||
** Treat hyperkalemia |
|||
** Do NOT treat hypocalcemia |
|||
* Leukostasis (in AML more than any other) |
|||
** Lungs and brain most commonly affected |
|||
** Cytoreduction |
|||
*** Induction chemotherapy as soon as possilble |
|||
*** Overnight, give hydroxyurea 2g q6h |
|||
**** Can develop tumour lysis syndrome |
|||
*** No evidence for leukopheresis |
|||
* APL is suspected |
|||
** Consult heme/onc overnight |
|||
** Start ATRA 45mg/m2 divided BID |
|||
** Beware differentiation syndrome, with fever, effusion, dyspnea, hypotension; treated with steroids |
|||
** Beware DIC |
|||
*** Follow q6h bloodwork |
|||
*** Transfuse platelets ≥ 30 |
|||
*** Cryoprecipitate to keep fibrinogen ≥ 1.5 (regardless of bleeding) |
|||
*** Plasmia to keep INR < 1.5 |
|||
*** AVOID tranexamic acid |
|||
=== |
==== ALL ==== |
||
*Dana-Farber protocol |
|||
* AML |
|||
*2+ years of chemo + steroids |
|||
** Induction with 3+7: 3 days of daunorubicin and 7 days of cytarabine, includes about a month as inpatient |
|||
*For Philadelphia positive disease, add imatinib |
|||
** BM to confirm induction, then consolidation |
|||
*** Low risk: 2-3 more cycles of same |
|||
*** High/poor risk: 1-2 more cycles, then alloSCT |
|||
* APL |
|||
** ATRA + arsenic trioxide |
|||
* ALL |
|||
** Dana-Farber protocol |
|||
** 2+ years of chemo + steroids |
|||
** For Philadelphia positive disease, add imatinib |
|||
[[Category:Hematology]] |
[[Category:Hematology]] |
Revision as of 15:44, 30 July 2020
Clinical Manifestations
- Often cytopenia-related symptoms
Differential Diagnosis
- Primary: suspect when multiple lineages affected, significant leukocytosis, lymphadenopathy, splenomegaly
- Secondary
- Acute infection (30-50%)
- Chronic inflammation
- Stress (MI, surgery, burn) (30-50%)
- Steroids
- Pregnancy
- Cigarette smoking
Investigations
- Urgent blood film review to r/o APL
Management
Acute
Tumour lysis syndrome
- 2 or more: hyperkalemia, hyperphosphatemia, hypocalcemia, hyperuricemia
- Causes acute kidney injury, seizures, arrhythmias
- Hydration with normal saline (don't supplement electrolytes), target urine output of 80-100 mL/m2/h
- Rasburicase to get rid of uric acid (may need to call Nephrology)
- Treat hyperkalemia
- Do NOT treat hypocalcemia
Leukostasis
- More common in AML than any other
- Lungs and brain most commonly affected
- Cytoreduction
- Induction chemotherapy as soon as possilble
- Overnight, give hydroxyurea 2g q6h
- Can develop tumour lysis syndrome
- No evidence for leukopheresis
Suspected APL
- Consult Hematology overnight
- Start ATRA 45mg/m2 divided BID
- Beware differentiation syndrome, with fever, effusion, dyspnea, hypotension; treated with steroids
- Beware DIC
- Follow q6h bloodwork
- Transfuse platelets ≥ 30
- Cryoprecipitate to keep fibrinogen ≥ 1.5 (regardless of bleeding)
- Plasma to keep INR < 1.5
- AVOID tranexamic acid
Chronic
AML
- Induction with 3+7: 3 days of daunorubicin and 7 days of cytarabine, includes about a month as inpatient
- BM to confirm induction, then consolidation
- Low risk: 2-3 more cycles of same
- High/poor risk: 1-2 more cycles, then alloSCT
APL
- ATRA + arsenic trioxide
ALL
- Dana-Farber protocol
- 2+ years of chemo + steroids
- For Philadelphia positive disease, add imatinib